A COVID-19-hez kapcsolódó májenzim-emelkedés valószínuleg multifaktoriális eredetu.
Orv Hetil
; 163(36): 1415-1421, 2022 Sep 04.
Article
in English
| MEDLINE | ID: covidwho-2260234
ABSTRACT
Elevation of serum hepatic enzymes are common during the course of COVID-19. There are three possible mechanisms behind this phenomenon 1) direct and indirect cytotoxic effects of SARS-CoV-2, 2) pharmacological side effects of COVID-19 drugs (e.g., remdesivir, favipiravir, tocilizumab, baricitinib, systemic corticosteroids, etc.) and 3) the progression of chronic hepatic diseases. Both the differential diagnosis and the clinical decision-making may pose difficulty for the the astute clinician, as an inappropriate treatment may result in COVID-19 progression or liver function deterioration. This review aims to provide basic guidance on the clinical decision-making for physicians managing patients with COVID-19. Orv Hetil. 2022; 163(36) 1415-1421.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Drug Treatment
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Orv Hetil
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS